Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ALGN's Cash to Debt is ranked higher than
98% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. ALGN: No Debt )
Ranked among companies with meaningful Cash to Debt only.
ALGN' s 10-Year Cash to Debt Range
Min: 5.57  Med: 10000.00 Max: No Debt
Current: No Debt
Equity to Asset 0.77
ALGN's Equity to Asset is ranked higher than
69% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. ALGN: 0.77 )
Ranked among companies with meaningful Equity to Asset only.
ALGN' s 10-Year Equity to Asset Range
Min: 0.55  Med: 0.76 Max: 0.89
Current: 0.77
0.55
0.89
Interest Coverage No Debt
ALGN's Interest Coverage is ranked higher than
97% of the 168 Companies
in the Global Medical Devices industry.

( Industry Median: 10000.00 vs. ALGN: No Debt )
Ranked among companies with meaningful Interest Coverage only.
ALGN' s 10-Year Interest Coverage Range
Min: 22.24  Med: 10000.00 Max: 9999.99
Current: No Debt
22.24
9999.99
F-Score: 6
Z-Score: 14.84
M-Score: -2.82
WACC vs ROIC
15.68%
48.49%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 25.76
ALGN's Operating margin (%) is ranked higher than
94% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 3.12 vs. ALGN: 25.76 )
Ranked among companies with meaningful Operating margin (%) only.
ALGN' s 10-Year Operating margin (%) Range
Min: -3577.86  Med: 3.14 Max: 26.54
Current: 25.76
-3577.86
26.54
Net-margin (%) 19.20
ALGN's Net-margin (%) is ranked higher than
92% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.45 vs. ALGN: 19.20 )
Ranked among companies with meaningful Net-margin (%) only.
ALGN' s 10-Year Net-margin (%) Range
Min: -3750.61  Med: 2.88 Max: 26.31
Current: 19.2
-3750.61
26.31
ROE (%) 20.54
ALGN's ROE (%) is ranked higher than
91% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. ALGN: 20.54 )
Ranked among companies with meaningful ROE (%) only.
ALGN' s 10-Year ROE (%) Range
Min: -1345.04  Med: 10.77 Max: 42.13
Current: 20.54
-1345.04
42.13
ROA (%) 15.79
ALGN's ROA (%) is ranked higher than
95% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: -0.62 vs. ALGN: 15.79 )
Ranked among companies with meaningful ROA (%) only.
ALGN' s 10-Year ROA (%) Range
Min: -202.5  Med: 7.53 Max: 31.86
Current: 15.79
-202.5
31.86
ROC (Joel Greenblatt) (%) 215.29
ALGN's ROC (Joel Greenblatt) (%) is ranked higher than
99% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. ALGN: 215.29 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ALGN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -577.12  Med: 44.77 Max: 369.18
Current: 215.29
-577.12
369.18
Revenue Growth (3Y)(%) 15.80
ALGN's Revenue Growth (3Y)(%) is ranked higher than
84% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. ALGN: 15.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ALGN' s 10-Year Revenue Growth (3Y)(%) Range
Min: 7.6  Med: 15.40 Max: 144.4
Current: 15.8
7.6
144.4
EBITDA Growth (3Y)(%) 24.20
ALGN's EBITDA Growth (3Y)(%) is ranked higher than
81% of the 171 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. ALGN: 24.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ALGN' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -35.2  Med: 23.15 Max: 44.9
Current: 24.2
-35.2
44.9
EPS Growth (3Y)(%) 28.70
ALGN's EPS Growth (3Y)(%) is ranked higher than
81% of the 170 Companies
in the Global Medical Devices industry.

( Industry Median: -2.00 vs. ALGN: 28.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ALGN' s 10-Year EPS Growth (3Y)(%) Range
Min: -76.1  Med: 4.95 Max: 289.3
Current: 28.7
-76.1
289.3
» ALGN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

ALGN Guru Trades in Q2 2014

Ken Fisher 21,118 sh (New)
Mariko Gordon 79,953 sh (New)
Pioneer Investments 188,427 sh (+11.20%)
Steven Cohen 436,800 sh (unchged)
Ron Baron 29,800 sh (unchged)
Paul Tudor Jones Sold Out
Mario Gabelli 12,500 sh (-7.41%)
Jim Simons 489,381 sh (-35.44%)
Joel Greenblatt 18,854 sh (-90.59%)
» More
Q3 2014

ALGN Guru Trades in Q3 2014

Paul Tudor Jones 9,098 sh (New)
Joel Greenblatt 841,070 sh (+4360.96%)
Mariko Gordon 87,435 sh (+9.36%)
Pioneer Investments 269,165 sh (unchged)
Ron Baron 27,500 sh (-7.72%)
Mario Gabelli 10,000 sh (-20.00%)
Steven Cohen 254,800 sh (-41.67%)
Ken Fisher 9,228 sh (-56.30%)
Jim Simons 158,281 sh (-67.66%)
» More
Q4 2014

ALGN Guru Trades in Q4 2014

Columbia Wanger 493,000 sh (New)
Chuck Royce 17,500 sh (New)
Ken Fisher 10,528 sh (+14.09%)
Pioneer Investments 298,599 sh (+10.94%)
Mariko Gordon 93,435 sh (+6.86%)
Ron Baron 27,500 sh (unchged)
Paul Tudor Jones 8,562 sh (-5.89%)
Jim Simons 142,681 sh (-9.86%)
Mario Gabelli 9,000 sh (-10.00%)
Steven Cohen 65,700 sh (-74.22%)
Joel Greenblatt 29,717 sh (-96.47%)
» More
Q1 2015

ALGN Guru Trades in Q1 2015

Steven Cohen 1,019,021 sh (+1451.02%)
Joel Greenblatt 45,553 sh (+53.29%)
Jim Simons 172,179 sh (+20.67%)
Columbia Wanger 584,000 sh (+18.46%)
Paul Tudor Jones 9,374 sh (+9.48%)
Ken Fisher 10,528 sh (unchged)
Mario Gabelli 9,000 sh (unchged)
Ron Baron 27,500 sh (unchged)
Chuck Royce Sold Out
Pioneer Investments 284,250 sh (-4.81%)
Mariko Gordon 81,033 sh (-13.27%)
» More
» Details

Insider Trades

Latest Guru Trades with ALGN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 34.76
ALGN's P/E(ttm) is ranked lower than
62% of the 155 Companies
in the Global Medical Devices industry.

( Industry Median: 28.20 vs. ALGN: 34.76 )
Ranked among companies with meaningful P/E(ttm) only.
ALGN' s 10-Year P/E(ttm) Range
Min: 5.22  Med: 32.13 Max: 405.23
Current: 34.76
5.22
405.23
Forward P/E 28.82
ALGN's Forward P/E is ranked lower than
66% of the 97 Companies
in the Global Medical Devices industry.

( Industry Median: 22.68 vs. ALGN: 28.82 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 34.40
ALGN's PE(NRI) is ranked lower than
63% of the 153 Companies
in the Global Medical Devices industry.

( Industry Median: 28.20 vs. ALGN: 34.40 )
Ranked among companies with meaningful PE(NRI) only.
ALGN' s 10-Year PE(NRI) Range
Min: 5.21  Med: 32.16 Max: 445.75
Current: 34.4
5.21
445.75
P/B 6.45
ALGN's P/B is ranked lower than
79% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 3.23 vs. ALGN: 6.45 )
Ranked among companies with meaningful P/B only.
ALGN' s 10-Year P/B Range
Min: 1.86  Med: 4.89 Max: 15.9
Current: 6.45
1.86
15.9
P/S 6.66
ALGN's P/S is ranked lower than
73% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.28 vs. ALGN: 6.66 )
Ranked among companies with meaningful P/S only.
ALGN' s 10-Year P/S Range
Min: 1.31  Med: 4.06 Max: 7.94
Current: 6.66
1.31
7.94
PFCF 24.74
ALGN's PFCF is ranked higher than
67% of the 114 Companies
in the Global Medical Devices industry.

( Industry Median: 32.21 vs. ALGN: 24.74 )
Ranked among companies with meaningful PFCF only.
ALGN' s 10-Year PFCF Range
Min: 11.21  Med: 23.22 Max: 2846
Current: 24.74
11.21
2846
POCF 21.17
ALGN's POCF is ranked higher than
53% of the 148 Companies
in the Global Medical Devices industry.

( Industry Median: 21.95 vs. ALGN: 21.17 )
Ranked among companies with meaningful POCF only.
ALGN' s 10-Year POCF Range
Min: 8.39  Med: 19.03 Max: 338.5
Current: 21.17
8.39
338.5
EV-to-EBIT 22.98
ALGN's EV-to-EBIT is ranked lower than
52% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 22.01 vs. ALGN: 22.98 )
Ranked among companies with meaningful EV-to-EBIT only.
ALGN' s 10-Year EV-to-EBIT Range
Min: -215.4  Med: 22.00 Max: 187
Current: 22.98
-215.4
187
Shiller P/E 71.39
ALGN's Shiller P/E is ranked lower than
78% of the 95 Companies
in the Global Medical Devices industry.

( Industry Median: 31.07 vs. ALGN: 71.39 )
Ranked among companies with meaningful Shiller P/E only.
ALGN' s 10-Year Shiller P/E Range
Min: 30.52  Med: 62.57 Max: 136.15
Current: 71.39
30.52
136.15
Current Ratio 3.28
ALGN's Current Ratio is ranked higher than
58% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 2.53 vs. ALGN: 3.28 )
Ranked among companies with meaningful Current Ratio only.
ALGN' s 10-Year Current Ratio Range
Min: 1.59  Med: 3.02 Max: 6.96
Current: 3.28
1.59
6.96
Quick Ratio 3.20
ALGN's Quick Ratio is ranked higher than
66% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. ALGN: 3.20 )
Ranked among companies with meaningful Quick Ratio only.
ALGN' s 10-Year Quick Ratio Range
Min: 1.55  Med: 2.95 Max: 6.82
Current: 3.2
1.55
6.82
Days Inventory 29.48
ALGN's Days Inventory is ranked higher than
93% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 129.39 vs. ALGN: 29.48 )
Ranked among companies with meaningful Days Inventory only.
ALGN' s 10-Year Days Inventory Range
Min: 9.28  Med: 16.45 Max: 32.75
Current: 29.48
9.28
32.75
Days Sales Outstanding 64.73
ALGN's Days Sales Outstanding is ranked higher than
57% of the 276 Companies
in the Global Medical Devices industry.

( Industry Median: 68.45 vs. ALGN: 64.73 )
Ranked among companies with meaningful Days Sales Outstanding only.
ALGN' s 10-Year Days Sales Outstanding Range
Min: 51.64  Med: 63.06 Max: 278.86
Current: 64.73
51.64
278.86

Valuation & Return

vs
industry
vs
history
Price/Net Cash 24.34
ALGN's Price/Net Cash is ranked lower than
66% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 14.31 vs. ALGN: 24.34 )
Ranked among companies with meaningful Price/Net Cash only.
ALGN' s 10-Year Price/Net Cash Range
Min: 2.22  Med: 18.67 Max: 417
Current: 24.34
2.22
417
Price/Net Current Asset Value 12.10
ALGN's Price/Net Current Asset Value is ranked lower than
71% of the 205 Companies
in the Global Medical Devices industry.

( Industry Median: 6.76 vs. ALGN: 12.10 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ALGN' s 10-Year Price/Net Current Asset Value Range
Min: 1.74  Med: 7.56 Max: 25.69
Current: 12.1
1.74
25.69
Price/Tangible Book 7.18
ALGN's Price/Tangible Book is ranked lower than
66% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 4.56 vs. ALGN: 7.18 )
Ranked among companies with meaningful Price/Tangible Book only.
ALGN' s 10-Year Price/Tangible Book Range
Min: 1.17  Med: 5.26 Max: 16.39
Current: 7.18
1.17
16.39
Price/Projected FCF 2.19
ALGN's Price/Projected FCF is ranked lower than
52% of the 112 Companies
in the Global Medical Devices industry.

( Industry Median: 1.95 vs. ALGN: 2.19 )
Ranked among companies with meaningful Price/Projected FCF only.
ALGN' s 10-Year Price/Projected FCF Range
Min: 1.38  Med: 2.23 Max: 14.76
Current: 2.19
1.38
14.76
Price/Median PS Value 1.64
ALGN's Price/Median PS Value is ranked lower than
73% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 1.16 vs. ALGN: 1.64 )
Ranked among companies with meaningful Price/Median PS Value only.
ALGN' s 10-Year Price/Median PS Value Range
Min: 0.43  Med: 1.02 Max: 8.11
Current: 1.64
0.43
8.11
Price/Peter Lynch Fair Value 1.79
ALGN's Price/Peter Lynch Fair Value is ranked higher than
67% of the 30 Companies
in the Global Medical Devices industry.

( Industry Median: 2.64 vs. ALGN: 1.79 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
ALGN' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.57  Med: 2.13 Max: 14.72
Current: 1.79
0.57
14.72
Price/Graham Number 3.30
ALGN's Price/Graham Number is ranked lower than
64% of the 138 Companies
in the Global Medical Devices industry.

( Industry Median: 2.43 vs. ALGN: 3.30 )
Ranked among companies with meaningful Price/Graham Number only.
ALGN' s 10-Year Price/Graham Number Range
Min: 0.85  Med: 2.99 Max: 17.12
Current: 3.3
0.85
17.12
Earnings Yield (Greenblatt) (%) 4.35
ALGN's Earnings Yield (Greenblatt) (%) is ranked higher than
74% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 0.20 vs. ALGN: 4.35 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ALGN' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.5  Med: 3.90 Max: 9.7
Current: 4.35
0.5
9.7
Forward Rate of Return (Yacktman) (%) 22.10
ALGN's Forward Rate of Return (Yacktman) (%) is ranked higher than
88% of the 98 Companies
in the Global Medical Devices industry.

( Industry Median: 4.08 vs. ALGN: 22.10 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ALGN' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -10  Med: 2.30 Max: 22.6
Current: 22.1
-10
22.6

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:AFW.Germany,
Align Technology Inc was founded in March 1997 and incorporated in Delaware in April 1997. The Company designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The Company has two operating segments: Clear Aligner segment and SCCS segment. Its Clear Aligner segment consists of its Invisalign System which includes Invisalign Full, Express/Lite, Teen, Assist, Vivera Retainers, along with its training and ancillary products for treating malocclusion. The SCCS segment consists of intra-oral scanning systems, and additional services available with the intra-oral scanners, that provide digital alternatives to the traditional cast models. This segment includes its iTero scanner and OrthoCAD services. The Company distributes its products directly to its customers: orthodontists and general practitioner dentists as well as to restorative dentists, including prosthodontists, periodontists, and oral surgeons. The Companys manufacturing facilities are located in Juarez, Mexico, where it conduct its aligner fabrication, distribute and repair its scanners, perform its CAD/CAM services, and in Or Yehuda, Israel where it produce its handheld intra-oral scanner wand. As of December 31, 2013, the Company had 313 issued U.S. patents, 124 pending U.S. patent applications, and 239 foreign issued patents, as well as 116 pending foreign patent applications. Its trademarks include Invisalign, Align, ClinCheck, Invisalign Assist, Invisalign Teen, Vivera, SmartForce, SmartTrack, Power Ridge and iTero. The Company competes with Danaher Corporation, 3M, Sirona Dental Systems, Inc., Dentsply International, Inc. and among others. The Company is subject to various laws inside and outside the U.S. concerning its relationships with healthcare professionals and government officials, price reporting and regulation, the promotion, sales and marketing of its products and services, the importation and exportation of its products, the operation of its facilities and distribution of its products. It is also subject to varying degrees of government regulation in the various countries in which the Company do business.
» More Articles for ALGN

Headlines

Articles On GuruFocus.com
Align Technology to Announce Second Quarter 2015 Results on July 23, 2015 Jul 01 2015 
Align Technology to Present at Upcoming Financial Conferences May 21 2015 
Align Technology to Present at Upcoming J.P. Morgan Healthcare Conference Jan 08 2015 
Align Technology to Announce Fourth Quarter and Fiscal Year 2014 Results on January 29, 2015 Jan 02 2015 
Align Technology Launches Chairside CAD/CAM Workflow With IOS Technologies for the iTero Scanner Nov 28 2014 
Align Technology to Present at Upcoming Financial Conferences Nov 25 2014 
Align Technology Continues Research Award Program for 2015 Nov 03 2014 
Align Technology to Present at Upcoming Financial Conferences Oct 29 2014 
Align Technology to Announce Third Quarter 2014 Results on October 23, 2014 Oct 15 2014 
Valeant Pharmaceuticals Part X: a follow up on the sale of facial injectables Aug 11 2014 

More From Other Websites
Align Technology to Announce Second Quarter 2015 Results on July 23, 2015 Jul 01 2015
/C O R R E C T I O N -- Bronstein, Gewirtz & Grossman, LLC/ Jun 25 2015
Align Technology Slumps on Patent Challenges to Clear Braces Jun 17 2015
ALIGN TECHNOLOGY INC Files SEC form 8-K, Other Events Jun 17 2015
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Align Technology... Jun 17 2015
Edited Transcript of ALGN presentation 10-Jun-15 7:00pm GMT Jun 11 2015
ALIGN TECHNOLOGY INC Files SEC form 8-K, Change in Directors or Principal Officers Jun 05 2015
Put sellers show support for Align Jun 04 2015
Align Technology to Present at Upcoming Financial Conferences May 21 2015
Align Technology to Present at Upcoming Financial Conferences May 21 2015
ALIGN TECHNOLOGY INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 14 2015
Align Technology Awards $310,000 as Part of Its University Research Award Program 2015 for... May 14 2015
Align Technology Awards $310,000 as Part of Its University Research Award Program 2015 for... May 14 2015
Align Technology Announces 10b5-1 Stock Repurchase Plan May 04 2015
ALIGN TECHNOLOGY INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 04 2015
Align Technology Announces 10b5-1 Stock Repurchase Plan May 04 2015
10-Q for Align Technology, Inc. May 03 2015
ALIGN TECHNOLOGY INC Files SEC form 10-Q, Quarterly Report May 01 2015
ALIGN TECHNOLOGY INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Apr 29 2015
Align Technology Announces $70 Million Accelerated Stock Repurchase Agreement as Part of Previously... Apr 28 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK